IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Crestline Management, L.P.

Q1 2026 Holdings

Filed 2026-05-15 | 3 holdings | $46.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-05-15) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Denali Therapeutics Inc(DNLI)COM24823R105$42.4M2,210,73291.7%
Sana Biotechnology Inc(SANA)COM799566104$2.2M755,7364.7%
8X8 Inc New(EGHT)COM282914100$1.6M990,8503.6%